 |
 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 December 1993 | Volume 119 Issue 12 | Pages 1181-1186
Objective: To determine the relative risk for human immunodeficiency virus (HIV-1) seroconversion in patients with and without genital ulcers caused by chancroid, syphilis, and herpes.
Design: A prospective cohort study.
Setting: An inner-city, sexually transmitted disease clinic.
Patients: Patients seronegative for HIV-1 with and without genital ulcers who were followed for a minimum of 3 months.
Interventions: Questionnaire to obtain data on demographics, sexual behavior, and illicit drug use; testing for HIV-1 at entry and at a minimum of 3 months after entry; medical examination for the presence or absence of genital ulcer disease.
Results: Overall, 758 heterosexual men with no history of injection drug use completed the study; HIV-1 seroconversion occurred in 10 of 344 (2.9%; 95% CI, 1.4% to 5.3%) men with a genital ulcer and in 4 of 414 (1%; CI, 0.2% to 2.5%) without a genital ulcer (relative risk, 3.0; P = 0.05). In a multiple logistic regression analysis, those men with chancroid and a new sexually transmitted disease during follow-up each had about three times the risk for HIV-1 seroconversion (P
Conclusions: In this group of heterosexual men, chancroid and repeated acquisition of sexually transmitted diseases appeared to facilitate the sexual transmission of HIV-1.
Author and Article Information
From the New York City Department of Health, New York, New York; the Bronx-Lebanon Hospital Center, Albert Einstein College of Medicine, Bronx, New York; the Centers for Disease Control and Prevention, Atlanta, Georgia.
ARTICLE
HIV-1 Seroconversion in Patients with and without Genital Ulcer Disease: A Prospective Study
0.04).
Requests for Reprints: Edward E. Telzak, MD, Division of Infectious Diseases, Bronx Lebanon Hospital Center, Albert Einstein College of Medicine, 1650 Grand Concourse, Bronx, NY 10457.
Acknowledgments: The authors thank Steve Blum, PhD, from the New York City Department of Health for his epidemiologic guidance and comments throughout the course of the study; Jesus Rivera, Deborah Hildebrandt, William E. Ewing, Richard Heffernan, Eneida Garafalo, and Richard Munoz for their hard work and practical insights; and Drs. Debra Hanson, John Karon, and Meade Morgan from the Division of HIV/AIDS, National Center for Infectious Diseases, Centers for Disease Control and Prevention, for their statistical support and comments.
Grant Support: In part by Centers for Disease Control and Prevention #U64/CCU203312.
This article has been cited by other articles:
|
|
 |
|
  D. M. B. Post, R. S. Munson Jr., B. Baker, H. Zhong, J. A. Bozue, and B. W. Gibson Identification of Genes Involved in the Expression of Atypical Lipooligosaccharide Structures from a Second Class of Haemophilus ducreyi Infect. Immun., January 1, 2007; 75(1): 113 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S J Reynolds, A R Risbud, M E Shepherd, A M Rompalo, M V Ghate, S V Godbole, S N Joshi, A D Divekar, R R Gangakhedkar, R C Bollinger, et al. High rates of syphilis among STI patients are contributing to the spread of HIV-1 in India. Sex Transm Inf, April 1, 2006; 82(2): 121 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Mbwana, I. Bolin, E. Lyamuya, F. Mhalu, and T. Lagergard Molecular Characterization of Haemophilus ducreyi Isolates from Different Geographical Locations J. Clin. Microbiol., January 1, 2006; 44(1): 132 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. B. Post, R. Mungur, B. W. Gibson, and R. S. Munson Jr. Identification of a Novel Sialic Acid Transporter in Haemophilus ducreyi Infect. Immun., October 1, 2005; 73(10): 6727 - 6735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Roy-Leon, W. D. Lauzon, B. Toye, N. Singhal, and D. W. Cameron In vitro and in vivo activity of combination antimicrobial agents on Haemophilus ducreyi J. Antimicrob. Chemother., September 1, 2005; 56(3): 552 - 558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. Smith, G. Meng, J. F. Salazar-Gonzalez, and G. M. Shaw Macrophage HIV-1 infection and the gastrointestinal tract reservoir J. Leukoc. Biol., November 1, 2003; 74(5): 642 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Kebaabetswe, S Lockman, S Mogwe, R Mandevu, I Thior, M Essex, and R L Shapiro Male circumcision: an acceptable strategy for HIV prevention in Botswana Sex Transm Inf, June 1, 2003; 79(3): 214 - 219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Nika, J. L. Latimer, C. K. Ward, R. J. Blick, N. J. Wagner, L. D. Cope, G. G. Mahairas, R. S. Munson Jr., and E. J. Hansen Haemophilus ducreyi Requires the flp Gene Cluster for Microcolony Formation In Vitro Infect. Immun., June 1, 2002; 70(6): 2965 - 2975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Ahmed, C. Johansson, L. A. Svensson, K. Ahlman, M. Verdrengh, and T. Lagergard In Vitro and In Vivo Interactions of Haemophilusducreyi with Host Phagocytes Infect. Immun., February 1, 2002; 70(2): 899 - 908. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.J. AHMED, L.A. SVENSSON, L.D. COPE, J.L. LATIMER, E.J. HANSEN, K. AHLMAN, J. BAYAT-TURK, D. KLAMER, and T. LAGERGARD Prevalence of cdtABC genes encoding cytolethal distending toxin among Haemophilus ducreyi and Actinobacillus actinomycetemcomitans strains J. Med. Microbiol., October 1, 2001; 50(10): 860 - 864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A Diseker III, T. A Peterman, M. L Kamb, C. Kent, J. M Zenilman, J. M Douglas Jr, F. Rhodes, and M. Iatesta Circumcision and STD in the United States: cross sectional and cohort analyses Sex Transm Inf, December 1, 2000; 76(6): 474 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. O'Farrell Chancroid in the United Kingdom Sex Transm Inf, April 1, 2000; 76(2): 67 - 68. [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Tellier, G. Greco, M. Klotman, A. Mosoian, A. Cara, W. Arap, E. Ruoslahti, R. Pasqualini, and L. M. Schnapp Superfibronectin, a Multimeric Form of Fibronectin, Increases HIV Infection of Primary CD4+ T Lymphocytes J. Immunol., March 15, 2000; 164(6): 3236 - 3245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Totten, J. M. Kuypers, C.-Y. Chen, M. J. Alfa, L. M. Parsons, S. M. Dutro, S. A. Morse, and N. B. Kiviat Etiology of Genital Ulcer Disease in Dakar, Senegal, and Comparison of PCR and Serologic Assays for Detection of Haemophilus ducreyi J. Clin. Microbiol., January 1, 2000; 38(1): 268 - 273. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. L. Severson and S. K. Tyring Relation Between Herpes Simplex Viruses and Human Immunodeficiency Virus Infections Arch Dermatol, November 1, 1999; 135(11): 1393 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Bozue, M. V. Tullius, J. Wang, B. W. Gibson, and R. S. Munson Jr. Haemophilus ducreyi Produces a Novel Sialyltransferase. IDENTIFICATION OF THE SIALYLTRANSFERASE GENE AND CONSTRUCTION OF MUTANTS DEFICIENT IN THE PRODUCTION OF THE SIALIC ACID-CONTAINING GLYCOFORM OF THE LIPOOLIGOSACCHARIDE J. Biol. Chem., February 12, 1999; 274(7): 4106 - 4114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fortney, P. A. Totten, R. I. Lehrer, and S. M. Spinola Haemophilus ducreyi Is Susceptible to Protegrin Antimicrob. Agents Chemother., October 1, 1998; 42(10): 2690 - 2693. [Abstract] [Full Text]
|
|
|
|
|
|
A. Frisk, C. A. Ison, and T. Lagergard GroEL Heat Shock Protein of Haemophilus ducreyi: Association with Cell Surface and Capacity To Bind to Eukaryotic Cells Infect. Immun., March 1, 1998; 66(3): 1252 - 1257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Fleming, G. M. McQuillan, R. E. Johnson, A. J. Nahmias, S. O. Aral, F. K. Lee, and M. E. St. Louis Herpes Simplex Virus Type 2 in the United States, 1976 to 1994 N. Engl. J. Med., October 16, 1997; 337(16): 1105 - 1111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Pacello, P. R. Langford, J. S. Kroll, C. Indiani, G. Smulevich, A. Desideri, G. Rotilio, and A. Battistoni A Novel Heme Protein, the Cu,Zn-Superoxide Dismutase from Haemophilus ducreyi J. Biol. Chem., August 3, 2001; 276(32): 30326 - 30334. [Abstract] [Full Text] [PDF]
|
|
Article
